News|Articles|August 12, 2026
The performance gaps most fleet programs can’t see
Author(s)Element
How pharmaceutical and life sciences fleets can uncover hidden operational costs by connecting maintenance, telematics, fuel, routing, and lifecycle decisions
Related Content
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences
4
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion
5